Ridgecrest Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Ridgecrest Wealth Partners's LLY Position: Q2 2026 in Review
Ridgecrest Wealth Partners increased its Eli Lilly (LLY) stake by 2.8% in Q2 2026, buying an estimated $24.5K and bringing the position to 884 shares worth $1.06M. The position accounts for 0.51% of the portfolio, ranked #38.
Ridgecrest Wealth Partners first reported a position in LLY in Q3 2021 and has held it in 20 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Ridgecrest Wealth Partners held 884 shares of Eli Lilly worth $1.06M as of Q2 2026.
- Ridgecrest Wealth Partners bought 24 Eli Lilly shares in Q2 2026, an estimated $24.5K.
- Eli Lilly made up 0.51% of Ridgecrest Wealth Partners's portfolio in Q2 2026, its #38 holding.
- Ridgecrest Wealth Partners first reported a position in Eli Lilly in Q3 2021 and has held it in 20 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Ridgecrest Wealth Partners's 13F filing for Q2 2026, filed 5 Aug 2026.